These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26044559)

  • 1. Clinicopathological significance and biological role of TCF21 mRNA in breast cancer.
    Wang J; Gao X; Wang M; Zhang J
    Tumour Biol; 2015 Nov; 36(11):8679-83. PubMed ID: 26044559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.
    Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q
    Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of TCF21 on proliferation, migration and vascular production of breast cancer cells].
    Li PW; Wang HY; Xu LL
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):307-311. PubMed ID: 30955268
    [No Abstract]   [Full Text] [Related]  

  • 5. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF21 genetic polymorphisms and breast cancer risk in Chinese women.
    Gao X; Yang J; Wang M; Zhang J
    Oncotarget; 2016 Aug; 7(34):55757-55764. PubMed ID: 27270650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.
    Mokkapati S; Porten SP; Narayan VM; Lim AH; Jayaratna IS; Roth B; Cheng T; Navai N; Wszolek M; Melquist J; Manyam G; Choi W; Broom B; Pretzsch S; Czerniak B; McConkey DJ; Dinney CPN
    Mol Cancer Res; 2020 Jun; 18(6):811-821. PubMed ID: 32122956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.
    Gooskens SL; Klasson TD; Gremmels H; Logister I; Pieters R; Perlman EJ; Giles RH; van den Heuvel-Eibrink MM
    Mol Oncol; 2018 Feb; 12(2):166-179. PubMed ID: 29080283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
    Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
    Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
    Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
    Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.
    Elghonaimy EA; Ibrahim SA; Youns A; Hussein Z; Nouh MA; El-Mamlouk T; El-Shinawi M; Mostafa Mohamed M
    Tumour Biol; 2016 Sep; 37(9):12441-12453. PubMed ID: 27329104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achaete-scute complex homologue-1 promotes development of laryngocarcinoma via facilitating the epithelial-mesenchymal transformation.
    Ma H; Du X; Zhang S; Wang Q; Yin Y; Qiu X; Da P; Yue H; Wu H; Xu F
    Tumour Biol; 2017 Jun; 39(6):1010428317705752. PubMed ID: 28618959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
    Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis.
    Yang H; Wang B; Wang T; Xu L; He C; Wen H; Yan J; Su H; Zhu X
    PLoS One; 2014; 9(10):e109980. PubMed ID: 25299052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
    Li W; Zhai L; Zhao C; Lv S
    Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-10b sponge: An anti-breast cancer study in vitro.
    Liang AL; Zhang TT; Zhou N; Wu CY; Lin MH; Liu YJ
    Oncol Rep; 2016 Apr; 35(4):1950-8. PubMed ID: 26820121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.